Home | Clinical Care | Research | Training | Division Activities

Education and Training:

B.S. with Honors, University of Wisconsin-Madison (2000)

M.D. with Honors in Research, University of Wisconsin School of Medicine & Public Health (2007)

Residency in Internal Medicine, University of Wisconsin Hospital & Clinics (2007-2010)

Fellowship in Hematology and Oncology, University of Washington and Fred Hutchinson Cancer Research Center (2010-2013)

Ryan Cassaday, MD
Assistant Professor, Division of Hematology
University of Washington School of Medicine
Research Associate, Clinical Research Division
Fred Hutchinson Cancer Research Center

Office Address:
University of Washington
825 Eastlake Ave E, Box 358081, Mailstop G6075
Seattle, WA 98109

Phone:        (206) 288-1202
Fax:            (206) 288-1130
E-mail:        cassaday@u.washington.edu


Acute lymphoblastic leukemia, B-cell non-Hodgkin lymphoma, Hodgkin lymphoma


Testing novel treatments and developing improved risk-stratification methods for adults with acute lymphoblastic leukemia. Studying radioimmunotherapy-based conditioning regimens for stem cell transplantation as treatment for adults with high-risk lymphoma.


Cassaday RD, Malik J, Chang J. Regression of Hodgkin lymphoma after discontinuation of a tumor necrosis factor inhibitor for Crohn's disease: a case report and review of the literature. Clin Lymphoma Myeloma Leuk. 11(3):289-92, 2011.

Cassaday RD, Gopal AK. What is the role of transplantation for indolent lymphoma? In: Govindan R, ed. 2012 ASCO Educational Book. Alexandria, VA: American Society of Clinical Oncology; 494-500, 2012.

Cassaday RD, Gopal AK. Allogeneic hematopoietic cell transplantation in mantle cell lymphoma. Best Pract Res Clin Haematol. 25(2):165-74, Jun 2012.

Cassaday RD, Guthrie KA, Budde LE, Thompson L, Till BG, Press OW, Chauncey TR, Pagel JM, Petersdorf SH, Palanca-Wessels MC, Philip M, Bensinger WI, Holmberg LA, Shustov A, Green DJ, Libby EN, Maloney DG, Gopal AK. Specific features identify patients with relapsed/refractory mantle cell lymphoma benefitting from autologous hematopoietic cell transplantation. Biol Blood Marrow Transplant. 19(9):1403-6; Sept 2013.